Spread awareness by sharing and learning more. Post the social media graphic, sign up for a conference, March for Marrow, and AAMDSIF Global PNH Patient Registry! Learn more about PNH.
Paroxysmal Nocturnal Hemoglobinuria (PNH) Donate to Support Our Mission
Background: Although complement component 5 inhibitors (C5is) eculizumab eculizumab: Eculizumab (Soliris ®) is given as an IV into a vein at the doctor’s office or at a special
Pegcetacoplan Pegcetacoplan: EMPAVELI® is the first PNH treatment that binds to complement protein C3.
Paroxysmal nocturnal hemoglobinuria Paroxysmal nocturnal hemoglobinuria: (pa
Thrombophilia is one of the principal features of paroxysmal nocturnal hemoglobinuria paroxysma
Crovalimab Crovalimab: An experimental complement inhibitor C5 monoclonal antibody.
Crovalimab Crovalimab: An experimental complement inhibitor C5 monoclonal antibody.
